These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11874419

  • 21. Loss of parafibromin expression in a subset of parathyroid adenomas.
    Juhlin C, Larsson C, Yakoleva T, Leibiger I, Leibiger B, Alimov A, Weber G, Höög A, Villablanca A.
    Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma.
    Haven CJ, van Puijenbroek M, Karperien M, Fleuren GJ, Morreau H.
    J Pathol; 2004 Jan; 202(1):86-94. PubMed ID: 14694525
    [Abstract] [Full Text] [Related]

  • 25. A possible tumor suppressor gene for parathyroid adenomas.
    Iwasaki H.
    Int Surg; 1996 Jan; 81(1):71-6. PubMed ID: 8803711
    [Abstract] [Full Text] [Related]

  • 26. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
    Miedlich S, Krohn K, Lamesch P, Müller A, Paschke R.
    Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
    [Abstract] [Full Text] [Related]

  • 27. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.
    Teh BT, Farnebo F, Kristoffersson U, Sundelin B, Cardinal J, Axelson R, Yap A, Epstein M, Heath H, Cameron D, Larsson C.
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4204-11. PubMed ID: 8954016
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Analysis of the RAD54 gene on chromosome 1p as a potential tumor-suppressor gene in parathyroid adenomas.
    Carling T, Imanishi Y, Gaz RD, Arnold A.
    Int J Cancer; 1999 Sep 24; 83(1):80-2. PubMed ID: 10449612
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI, Vinagre J, Fonseca E, Barbosa E, Teixeira-Gomes J, Sobrinho-Simões M, Soares P.
    Eur J Endocrinol; 2013 Feb 24; 168(2):119-28. PubMed ID: 23093699
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas.
    Palanisamy N, Imanishi Y, Rao PH, Tahara H, Chaganti RS, Arnold A.
    J Clin Endocrinol Metab; 1998 May 24; 83(5):1766-70. PubMed ID: 9589690
    [Abstract] [Full Text] [Related]

  • 39. Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q.
    Hobbs MR, Pole AR, Pidwirny GN, Rosen IB, Zarbo RJ, Coon H, Heath H, Leppert M, Jackson CE.
    Am J Hum Genet; 1999 Feb 24; 64(2):518-25. PubMed ID: 9973288
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.